Manufacturing, Aseptic Processing

Apr 10, 2015
BioPharm International
By BioPharm International Editors
Baxter voluntarily recalls select lots of IV solutions due to possible particulate matter.
Apr 01, 2015
BioPharm International
Second-generation needle-free injection systems will make parenteral drug administration more convenient, efficient, and safe.
Mar 01, 2015
BioPharm International
It is important to understand degradation and processing to maintain product stability in biologics.
Feb 01, 2015
BioPharm International
Evaluating the assembly design process, manufacture, and use helps mitigate risk.
Jan 01, 2015
BioPharm International
By BioPharm International Editors
Nov 17, 2014
By BioPharm International Editors
Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.
Aug 25, 2014
By BioPharm International Editors
PSC Investments announces the acquisition of a high potency, sterile fill/finish pharmaceutical manufacturing facility.
Aug 08, 2014
By BioPharm International Editors
Cubist Pharmaceuticals voluntarily recalls certain lots of CUBICIN 500 mg in 10 mL single-use vials because of the presence of particulate matter.
Jul 22, 2014
By BioPharm International Editors
Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.
Jun 04, 2014
By BioPharm International Editors
FDA issues a Form 483 to Wockhardt for quality issues at Morton Grove, IL facility.
native1_300x100
lorem ipsum